References
- Barnaby, B., Drummond, C., McCloud, A., Burns, T., & Omu, N. (2003). Substance misuse in psychiatric inpatients: Comparison of a screening questionnaire survey with case notes. British Medical Journal, 327(7418), 783–784. https://doi.org/https://doi.org/10.1136/bmj.327.7418.783.
- Błachut, M., Ścisło, P., Jarząb, M., Zając, M., Piegza, M., Badura-Brzoza, K., & Gorczyca, P. (2019). Impact of dual diagnosis in patients with schizophrenia and affective disorders during hospital treatment on the course of illness and outcomes of treatment – a preliminary report. Psychiatria Polska, 53(6), 1237–1250. https://doi.org/https://doi.org/10.12740/PP/OnlineFirst/103352.
- Brady, K., Casto, S., Lydiard, R. B., Malcolm, R., & Arana, G. (1991). Substance abuse in an inpatient psychiatric sample. The American Journal of Drug and Alcohol Abuse, 17(4), 389–397. https://doi.org/https://doi.org/10.3109/00952999109001598.
- Buckley, P. F., & Brown, E. S. (2006). Prevalence and consequences of dual diagnosis. The Journal of Clinical Psychiatry, 67(7), e01. https://doi.org/https://doi.org/10.4088/jcp.0706e01.
- Chandra, S., Radwan, M. M., Majumdar, C. G., Church, J. C., Freeman, T. P., & ElSohly, M. A. (2019). New trends in cannabis potency in USA and Europe during the last decade (2008-2017). European Archives of Psychiatry Clinical Neuroscience, 269(1), 5–15. https://doi.org/https://doi.org/10.1007/s00406-019-00983-5.
- Dixon, L. (1999). Dual diagnosis of substance abuse in schizophrenia: Prevalence and impact on outcomes. Schizophrenia Research, 35(Suppl1), S93–S100. https://doi.org/https://doi.org/10.1016/S0920-9964(98)00161-3.
- Drake, R. E., & Brunette, M. F. (1998). Complications of severe mental illness related to alcohol and drug use disorders. Recent developments in alcoholism (Vol. 14, pp. 285–299). Springer.
- Florentin, S., Rosca, P., Raskin, S., Bdolah-Abram, T., & Neumark, Y. (2019). Psychiatric hospitalizations of chronic psychotic disorder patients with and without dual diagnosis, Israel, 1963–2016. Journal of Dual Diagnosis, 15(3), 130–139. https://doi.org/https://doi.org/10.1080/15504263.2019.1609149.
- Freeman, T. P., Groshkova, T., Cunningham, A., Sedefov, R., Griffiths, P., & Lynskey, M. T. (2019). Increasing potency and price of cannabis in Europe, 2006–16. Addiction, 114(6), 1015–1023. https://doi.org/https://doi.org/10.1111/add.14525.
- Graham, K., Cheng, J., Bernards, S., Wells, S., Rehm, J., & Kurdyak, P. (2017). How much do mental health and substance use/addiction affect use of general medical services? Extent of use, reason for use, and associated costs. The Canadian Journal of Psychiatry, 62(1), 48–56. https://doi.org/https://doi.org/10.1177/0706743716664884.
- Hansen, S. S., Munk-Jørgensen, P., Guldbaek, B., Solgård, T., Lauszus, K. S., Albrechtsen, N., Borg, L., Egander, A., Faurholdt, K., Gilberg, A., Gosden, N. P., Lorenzen, J., Richelsen, B., Weischer, K., & Bertelsen, A. (2000). Psychoactive substance use diagnoses among psychiatric in-patients. Acta Psychiatrica Scandinavica, 102(6), 432–438. https://doi.org/https://doi.org/10.1034/j.1600-0447.2000.102006432.x.
- Havassy, B. E., & Arns, P. G. (1998). Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients. Psychiatric Services, 49(7), 935–940. https://doi.org/https://doi.org/10.1176/ps.49.7.935.
- Hjorthøj, C., Østergaard, M. L. D., Benros, M. E., Toftdahl, N. G., Erlangsen, A., Andersen, J. T., & Nordentoft, M. (2015). Association between alcohol and substance use disorders and all-cause and cause-specific mortality in schizophrenia, bipolar disorder, and unipolar depression: A nationwide, prospective, register-based study. The Lancet Psychiatry, 2(9), 801–808. https://doi.org/https://doi.org/10.1016/S2215-0366(15)00207-2.
- Jiménez-Castro, L., Hare, E., Medina, R., Raventos, H., Nicolini, H., Mendoza, R., Ontiveros, A., Jerez, A., Muñoz, R., Dassori, A., & Escamilla, M. (2010). Substance use disorder comorbidity with schizophrenia in families of Mexican and Central American ancestry. Schizophrenia Research, 120(1–3), 87–94. https://doi.org/https://doi.org/10.1016/j.schres.2010.02.1053.
- Jørgensen, K. B., Nordentoft, M., & Hjorthøj, C. (2018). Association between alcohol and substance use disorders and psychiatric service use in patients with severe mental illness: A nationwide Danish register-based cohort study. Psychological Medicine, 48(15), 2592–2600. https://doi.org/https://doi.org/10.1017/S0033291718000223.
- Kim, H. J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000). Permutation tests for joinpoint regression with applications to cancer rates. Statistics in Medicine, 19(3), 335–351. https://doi.org/https://doi.org/10.1002/(SICI)1097-0258(20000215)19:3%3C335::AID-SIM336%3E3.0.CO;2-Z.
- Kim, J., & Kim, H.-J. (2016). Consistent model selection in segmented line regression. Journal of Statistical Planning and Inference, 170, 106–116. https://doi.org/https://doi.org/10.1016/j.jspi.2015.09.008.
- Lai, H. M. X., & Huang, Q. R. (2009). Comorbidity of mental disorders and alcohol- and drug-use disorders: Analysis of New South Wales inpatient data. Drug and Alcohol Review, 28(3), 235–242. https://doi.org/https://doi.org/10.1111/j.1465-3362.2008.00021.x.
- Large, M., Mullin, K., Gupta, P., Harris, A., & Nielssen, O. (2014). Systematic meta-analysis of outcomes associated with psychosis and co-morbid substance use. The Australian and New Zealand Journal of Psychiatry, 48(5), 418–432. https://doi.org/https://doi.org/10.1177/0004867414525838.
- Llanes-Álvarez, C., Alberola-López, C., Andrés-de-Llano, J. M., Álvarez-Navares, A. I., Pastor-Hidalgo, M. T., Roncero, C., Garmendia-Leiza, J. R., & Franco-Martín, M. A. (2021). Hospitalization trends and chronobiology for mental disorders in Spain from 2005 to 2015. Chronobiology International, 38(2), 286–295. https://doi.org/https://doi.org/10.1080/07420528.2020.1811719.
- McCrone, P., Menezes, P. R., Johnson, S., Scott, H., Thornicroft, G., Marshall, J., Bebbington, P., & Kuipers, E. (2000). Service use and costs of people with dual diagnosis in South London. Acta Psychiatrica Scandinavica, 101(6), 464–472. https://doi.org/https://doi.org/10.1034/j.1600-0447.2000.101006464.x.
- Menezes, P. R., Johnson, S., Thornicroft, G., Marshall, J., Prosser, D., Bebbington, P., & Kuipers, E. (1996). Drug and alcohol problems among individuals with severe mental illness in South London. The British Journal of Psychiatry, 168(5), 612–619. https://doi.org/https://doi.org/10.1192/bjp.168.5.612.
- Miles, H., Johnson, S., Amponsah-Afuwape, S., Finch, E., Leese, M., & Thornicroft, G. (2003). Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder. Psychiatric Services, 54(4), 554–561. https://doi.org/https://doi.org/10.1176/appi.ps.54.4.554.
- Miller, K. A., Hitschfeld, M. J., Lineberry, T. W., & Palmer, B. A. (2016). How does active substance use at psychiatric admission impact suicide risk and hospital length-of-stay? Journal of Addictive Diseases, 35(4), 291–297. https://doi.org/https://doi.org/10.1080/10550887.2016.1177808.
- Observatorio Español de las Drogas y las Adicciones. (2021). Consumo, percepciones y opiniones ante las drogas (Chapter number 1). In: Ministerio de Sanidad (Ed.), Informe 2021. Alcohol, tabaco y drogas ilegales en España (pp. 243). Delegación del Gobierno para el Plan Nacional sobre Drogas.
- Onukwugha, E., Saunders, E., Mullins, C. D., Pradel, F. G., Zuckerman, M., & Weir, M. R. (2010). Reasons for discharges against medical advice: A qualitative study. Quality & Safety in Health Care, 19(5), 420–424. https://doi.org/https://doi.org/10.1136/qshc.2009.036269.
- Ortiz-Medina, M. B., Perea, M., Torales, J., Ventriglio, A., Vitrani, G., Aguilar, L., & Roncero, C. (2018). Cannabis consumption and psychosis or schizophrenia development. The International Journal of Social Psychiatry, 64(7), 690–704. https://doi.org/https://doi.org/10.1177/0020764018801690.
- Pages, K. P., Russo, J. E., Wingerson, D. K., Ries, R. K., Roy-Byrne, P. P., & Cowley, D. S. (1998). Predictors and outcome of discharge against medical advice from the psychiatric units of a general hospital. Psychiatric Services, 49(9), 1187–1192. https://doi.org/https://doi.org/10.1176/ps.49.9.1187.
- Patel, D., Parsley, S., & Leck, A. (2017). Open education in eye health: Transforming access to learning. Community Eye Health, 30(100), 96–98.
- Patten, S. B. (2021). Cannabis and non-psychotic mental disorders. Current Opinion in Psychology, 38, 61–66. https://doi.org/https://doi.org/10.1016/j.copsyc.2020.09.006.
- Picci, R. L., Versino, E., Oliva, F., Giaretto, R. M., Ostacoli, L., Trivelli, F., Venturello, S., & Furlan, P. M. (2013). Does substance use disorder affect clinical expression in first-hospitalization patients with schizophrenia? Analysis of a prospective cohort. Psychiatry Research, 210(3), 780–786. https://doi.org/https://doi.org/10.1016/j.psychres.2013.08.043.
- Ponizovsky, A. M., Rosca, P., Haklai, Z., & Goldberger, N. (2015). Trends in dual diagnosis of severe mental illness and substance use disorders, 1996–2010, Israel. Drug and Alcohol Dependence, 148, 203–208. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2015.01.009.
- Ries, R. K., Russo, J., Wingerson, D., Snowden, M., Comtois, K. A., Srebnik, D., & Roy-Byrne, P. (2000). Shorter hospital stays and more rapid improvement among patients with schizophrenia and substance disorders. Psychiatric Services, 51(2), 210–215. https://doi.org/https://doi.org/10.1176/appi.ps.51.2.210.
- Rodríguez-Jiménez, R., Aragüés, M., Jiménez-Arriero, M. A., Ponce, G., Muñoz, A., Bagney, A., Hoenicka, J., & Palomo, T. (2008). Patología dual en pacientes psiquiátricos hospitalizados: Prevalencia y características generales. Investigación Clínica, 49(2), 195–205.
- Rømer Thomsen, K., Lindholst, C., Thylstrup, B., Kvamme, S., Reitzel, L. A., Worm-Leonhard, M., Englund, A., Freeman, T. P., & Hesse, M. (2019). Changes in the composition of cannabis from 2000-2017 in Denmark: Analysis of confiscated samples of cannabis resin. Experimental and Clinical Psychopharmacology, 27(4), 402–411. https://doi.org/https://doi.org/10.1037/pha0000303.
- Sara, G. E., Burgess, P. M., Malhi, G. S., Whiteford, H. A., & Hall, W. C. (2014). Stimulant and other substance use disorders in schizophrenia: Prevalence, correlates and impacts in a population sample. The Australian and New Zealand Journal of Psychiatry, 48(11), 1036–1047. https://doi.org/https://doi.org/10.1177/0004867414533838
- Schmidt, L. M., Hesse, M., & Lykke, J. (2011). The impact of substance use disorders on the course of schizophrenia-A 15-year follow-up study: Dual diagnosis over 15 years. Schizophrenia Research, 130(1–3), 228–233. https://doi.org/https://doi.org/10.1016/j.schres.2011.04.011.
- Soyka, M. (2000). Substance misuse, psychiatric disorder and violent and disturbed behaviour. The British Journal of Psychiatry, 176(4), 345–350. https://doi.org/https://doi.org/10.1192/bjp.176.4.345.
- Soyka, M., Albus, M., Kathmann, N., Finelli, A., Hofstetter, S., Holzbach, R., Immler, B., & Sand, P. (1993). Prevalence of alcohol and drug abuse in schizophrenic inpatients. European Archives of Psychiatry and Clinical Neuroscience, 242(6), 362–372. https://doi.org/https://doi.org/10.1007/BF02190250.
- Swendsen, J., Conway, K. P., Degenhardt, L., Glantz, M., Jin, R., Merikangas, K. R., Sampson, N., & Kessler, R. C. (2010). Mental disorders as risk factors for substance use, abuse and dependence: Results from the 10-year follow-up of the National Comorbidity Survey. Addiction, 105(6), 1117–1128. https://doi.org/https://doi.org/10.1111/j.1360-0443.2010.02902.x.
- Tindimwebwa, L., Ajayi, A. I., & Adeniyi, O. V. (2021). Prevalence and demographic correlates of substance use among adults with mental illness in Eastern Cape, South Africa: A cross-sectional study. International Journal of Environmental Research and Public Health, 18(10), 5428. https://doi.org/https://doi.org/10.3390/ijerph18105428.
- Toftdahl, N. G., Nordentoft, M., & Hjorthøj, C. (2016). Prevalence of substance use disorders in psychiatric patients: A nationwide Danish population-based study. Social Psychiatry and Psychiatric Epidemiology, 51(1), 129–140. https://doi.org/https://doi.org/10.1007/s00127-015-1104-4.
- Weich, L., & Pienaar, W. (2009). Occurrence of comorbid substance use disorders among acute psychiatric inpatients at Stikland Hospital in the Western Cape, South Africa. African Journal of Psychiatry, 12(3), 213–217. https://doi.org/https://doi.org/10.4314/ajpsy.v12i3.48496.
- Wobrock, T., Falkai, P., Schneider-Axmann, T., Hasan, A., Galderisi, S., Davidson, M., Kahn, R. S., Derks, E. M., Boter, H., Rybakowski, J. K., Libiger, J., Dollfus, S., López-Ibor, J. J., Peuskens, J., Hranov, L. G., Gaebel, W., Fleischhacker, W. W, & EUFEST study group. (2013). Comorbid substance abuse in first-episode schizophrenia: Effects on cognition and psychopathology in the EUFEST study. Schizophrenia Research, 147(1), 132–139. https://doi.org/https://doi.org/10.1016/j.schres.2013.03.001.
- Wu, H. E., Mohite, S., Ngana, I., Burns, W., Shah, N., Schneider, L., Schmitz, J. M., Lane, S. D., & Okusaga, O. O. (2015). Hospital length of stay in individuals with schizophrenia with and without cocaine-positive urine drug screens at hospital admission. Journal of Nervous & Mental Disease, 203(1), 33–36. https://doi.org/https://doi.org/10.1097/NMD.0000000000000231.
- Zammit, S., Moore, T. H. M., Lingford-Hughes, A., Barnes, T. R. E., Jones, P. B., Burke, M., & Lewis, G. (2008). Effects of cannabis use on outcomes of psychotic disorders: Systematic review. The British Journal of Psychiatry, 193(5), 357–363. https://doi.org/https://doi.org/10.1192/bjp.bp.107.046375.